Synthetic organic

CP-55940 is a cannabimimetic small molecule and a potent cannabinoid receptor agonist, demonstrating similar binding activity at both receptor types (CB1 K|i|=0.58 nM, CB2 K|i|=0.69 nM). CP-55940 represents a useful non-selective agonist entry into

CP-601927.

CP-601927.

CP-628006.

CP-628006.

CP 673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM, exhibits &gt:450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.

CP 673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM, exhibits &gt:450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.

CP 673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM, exhibits &gt:450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.

CP 673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM, exhibits &gt:450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.

CP 673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM, exhibits &gt:450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.

CP 673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM, exhibits &gt:450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.

Potent and selective ErbB2 inhibitor.